Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial-Reference-Cited by-同舟云学术

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

Published:2023-09 Issue:10404 Volume:402 Page:798-808
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Becker Jürgen C,Ugurel Selma,Leiter Ulrike,Meier Friedegund,Gutzmer Ralf,Haferkamp Sebastian,Zimmer Lisa,Livingstone Elisabeth,Eigentler Thomas K,Hauschild Axel,Kiecker Felix,Hassel Jessica C,Mohr Peter,Fluck Michael,Thomas Ioannis,Garzarolli Marlene,Grimmelmann Imke,Drexler Konstantin,Spillner Alexandra N,Eckhardt Sebastian,Schadendorf Dirk,van Akkooi Alexander,van Houdt Winan,Wilhelm Tabea,Farmer Kimberley,Ulrich Claas,Gambichler Thilo,Bluhm Leonie,Schinagl Heidemarie,Kellner Ivonne,Herbst Rudolf,Meiß Frank,Rafei-Shamsabadi David,Sell Sabine,Kaatz Martin,Wulfken Lena,Hartmann Martin,Kähler Katharina,Ziemer Mirjana,Simon Jan,Terheyden Patrick,Thaci Diamant,Loquai Carmen,Mitzel-Rink Heidrun,Grabbe Stephan,Stege Henner,Gaiser Maria,Utikal Jochen,Berking Carola,Heinzerling Lucie,Schlaak Max,Tomsitz Dirk,Dyballa Jörg,Magnolo Nina,Weishaupt Carsten,Berneburg Mark,Garbe Claus,Flatz Lukas,Gesierich Anja,Schilling Bastian

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline—update 2022;Gauci;Eur J Cancer,2022

2. Recurrence and mortality risk of Merkel cell carcinoma by cancer stage and time from diagnosis;McEvoy;JAMA Dermatol,2022

3. The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: an international assessment;Stang;Eur J Cancer,2018

4. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial;Kaufman;Lancet Oncol,2016

5. Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma;Nghiem;J Immunother Cancer,2021

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in the Management of Advanced Nonmelanoma Skin Cancer;Surgical Oncology Clinics of North America;2024-10

2. Merkel Cell Carcinoma;Hematology/Oncology Clinics of North America;2024-10

3. Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications;Journal of Clinical Oncology;2024-09-10

4. Reversal of T-cell exhaustion: Mechanisms and synergistic approaches;International Immunopharmacology;2024-09

5. Update Merkel-Zell-Karzinom;Die Onkologie;2024-08-14